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YEAST MANNANS: USE AS A TRANSPORT VEHICLE FOR PEPTIDES

Jacqueline Cesario Lee, M.S.
Western Michigan University, 1986

Yeast mannans are phosphorylated glycopeptides
species

of yeast.

Their

similarity to

found

in various

the mannose-phosphate signal

for intracellular lysosomal uptake led mannans to be considered as a
possible vehicle for increasing cellular affinity for peptides.

Insulin

was used as a model peptide and was conjugated to mannans by two coupling
methods.

The conjugated mannan-insulins were compared to insulin on

the basis of cellular binding and

ability

to induce typical

insulin

biological effects.
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INTRODUCTION

Since the turn of the century when Paul Ehrlich originated the concept
of using chemical

modification of antibiotics

as a means

to sharpen

the aim at bacterial targets, the search for "magic bullets" to improve
delivery of drugs

to specific

tissue and

cellular sites has been an

area of vigorous and imaginative research (Ehrlich, 1908).
current
drugs,

research

is

to optimize

therapeutic

primarily by directing the drug

doses

for

The aim of

a variety

to an identifiable

target

of
in

the body (site specific delivery) or away from sites where it may produce
toxic

effects

without

necessarily increasing

the drug at the target

site (site avoidance delivery) (Mufson, 1985).

The target site can be

broad (organ targeting) to encompass individual organs and tissues, or
it

can

be

directed

to particular

cells within

targeting) , even reaching organelles

the

tissue

(cellular

or compartments within the cell

(subcellular targeting) .
Strategies for delivering the drug to target sites can be divided
into three areas: anatomical, physical, and chemical.

A good carrier

must be able to provide protection for its drug cargo during transit,
as well
reached.

as allow controlled transfer of

the drug once the target is

The carrier should be biodegradable, nonimmunogenic, nontoxic

to the system, and as nearly chemically inert as possible.
The physical

approach involves changes

in the microenvironment.

One interesting concept is the use of magnetism to direct drug transport.
The carrier in this case consists of microspheres composed of albumin
1
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which are magnetically responsive, ranging in size from 0.2 - 1.5 urn.
The microspheres are injected into an artery supplying the target area,
over which a magnetic field has been placed.

The drug-containing micro

spheres are then concentrated in the target area and localized at the
capillary level, serving as a natural timed-release system.

This system

was effective in an experimental rat tumor model and shows promise for
treatment of tumors and chronic inflammatory conditions like arthritis
(Widder, 1985).
Strategies taking advantage of natural screening systems in the body
usually rely on size of the carrier, vascularity of the area, and the
interaction with

the

reticuloendothelial

drug to the desired organ.

system

(RES)

to direct

the

Particles less than 0.1 urn spread throughout

the vasculature, while those between 0.1 and 1.0 urn are taken up by the
RES (macrophages in the liver, spleen,
the blood).

The

route of

bone marrow,

injection does not

and monocytes in

seem to influence

efficacy of the RES in clearing the particles from circulation.
80 - 95% of the particles introduced end up in the RES.

the

Typically,

Larger particles,

in the range greater than 3.0 um, tend to lodge in the lungs.

Carrier

systems which have been used in this context include liposomes, micro
spheres, and red blood cells.
Liposomes are vesicles composed of phospholipids and may be single
layered

(unilamellar) or multi-layered

(multilamellar).

The

ability

of the liposome to encapsulate water-soluble drugs while maintaining a
compatible nature with
vehicle.

the

plasma membrane

make

them

an

attractive

To expand targeting potential beyond size-screening, liposomes

have been coupled to various molecules including antibodies and glycolipids
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(Mufson, 1985).

Disadvantages with liposome systems include poor drug

capture, leakage during transport, stability problems with storage, and
difficulty in controlling particle size

(Poste & Kirsh,

1983).

The

problems with leakage of aqueous contents of liposomes may be ameliorated
by the production of a new type of liposome (stable plurilamellar vesicle)
composed of the same phospholipids as multilamellar vehicles, but having
a more homogeneous distribution of aqueous compartments and more evenly
distributed osmotic pressure (Gruner, Lenk, Janoff, & Ostro, 1984).
Another novel drug transport method is the use of red blood cells.
Erythrocytes immersed in a drug solution tend
drug.

to absorb some of the

If the cells are returned to the body, some of the drug is slowly

released.

Surface modification with glutaraldehyde or sialidase will

encourage the RBC's to lodge in the spleen, while extensive modification
tends

to direct

disadvantages:

the cells

to the liver.

This

system has

two major

the organ specificity is limited and the preparation

of RBC's from each individual patient requires withdrawal of the blood,
encapsulation of the drug, and reinjection of the treated cells back
into the body (Sanders, 1985).
The anatomical aspect of targeted drug strategies has also included
the search for new sites for drug administration,
more traditional intravenous,
routes.

in addition to the

intrarterial, intraperitoneal, and oral

The skin and mucous membranes have both proved effective means

of introducing drugs into the body.

Transdermal

systems

are useful

with potent drugs which often are accompanied by undesirable side effects
like nitroglycerin and the anti-motion-sickness agent scopolamine.

These

systems are designed to deliver their contents into the general circulation
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and are not

targeted to a particular organ.

The

skin serves as the

primary determinant of diffusion rate, depending on both skin permeability
and the type of complex in which the drug is contained.

Transdermal

systems are divided into two types: the monolith, a matrix containing
a.semisolid solution of the drug and relying solely on the diffusion
rate of the skin; and the membrane, which incorporates the matrix with
a

permeability membrane

having

an upper

normal permeability of the skin.

rate

limit

about

twice

the

Both systems are applied as patches

(wearing time depends on the type of system) and may cause local skin
irritation and hypersensitization, especially when the patient is re
exposed to the drug by another route.
of

bypassing most

first-pass

degree of user compliance.

Transdermals have the advantage

hepatic metabolism,

as well

as

a high

Female reproductive hormones, cardiovascular

drugs, analgesics, and antihistamines are all being considered as possible
candidates for transdermal administration (Good, 1985).
The other promising site for nontraditional delivery is the nasal
mucous

membrane.

Transnasal

administration

of

drugs

has

been used

since ancient times, as in the inhalation of psychotrophic hallucinogens
by South American Indians.

More recent exploration of the nasal route

has included cardiovascular drugs

(propranolol, nitroglycerin), anti

microbials (especially those poorly absorbed orally), and a number of
hormones.

Nasal administration may be a good alternative for lipophilic

drugs like propranolol, which are easily absorbed.

It also has

benefit

while

of

avoiding

hepatic

first-pass

metabolism,

the

producing

blood levels similar to those obtained with intravenous administration
in some studies.

Compliance levels are good, especially when multiple
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daily dosing is required.

Nasal conditions (nasal obstruction due to

polyps, atrophic rhinitis, excessive secretion from irritants, nasal al
lergies) may affect delivery.

The administration of the rapidly absorbed

lipophilic hormones

adversely affected by colds or rhinitis.

are not

Peptides, however, are poorly absorbed and require adjuvants like bile
salts (Chien, 1985).
Chemical

strategies

of

site

specific

delivery

all

involve

the

attachment to a drug or carrier surface of some ligand which will direct
the drug

to

the desired

target.

Candidates

for

the

ligand include

monoclonal antibodies, carbohydrates specific for cell surface receptors,
toxinbinding subunits,

hormones,

and vitamins.

have been studied as ligands for liposomes.
the attachment

Monoclonal antibodies

In one conjugation system,

to the liposome is made through an activated sulfhydryl

reagent binding covalently to a sulfhydryl group on the antibody.

The

high specificity of the cell surface antigen to the liposome antibody
system makes it an attractive targeting device, but may be offset by
the small number of antigens on the surface of the cell.
antibodies have been suggested as ideal carriers for

Monoclonal

tumor targeting

and have been used successfully to locate the tumor site when the antibody
is attached to radioactive compounds that allow tumor imaging (Widder,
1985).

Establishing markers on tumor cells and the shedding of tumor

antigens into the circulation are obstacles to the
monoclonals as a site-specific system.

implementation of

In the mouse tumor model, se

questering of the delivery system by the RES was also a problem, but
was reduced

by pretreatment with non-drug containing liposomes prior

to injection of drug carrying vesicles (Mufson, 1985).
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Plant and microbial toxins are known to bind to specific receptors
on the surface of cells.
subunits*

These toxins are typically composed of two

one responsible for toxicity while the

for cell surface binding.
and

the

castor

agents.
were

used

bean

Glycolipids

is

essential

The binding subunits of the diphtheria toxin

toxin have

been

explored

(lactosylcerebroside

successfully

other

in vivo

mice (Szoka andMayhew, 1983).

to

direct

as

and

possible

targeting

dimannosyldiglyceride)

liposomes

to the liver in

The success of these in vivo drug targeting

ligands m ay lead to their use in the future treatment of human disease.
Peptides such as oxytocin, enkephalin, and insulin have been in
creasingly important as
the

lipophilic

peptides
into

peptides

a

class
are

of

pharmaceutical

readily

absorbed,

like insulin require the use

cells.

When

administered

orally,

degradation by proteolytic enzymes.
to deliver insulin into the body,

of

an

the

agents.

Although

nonlipophilic,

adjuvant
peptide

large

to gain entry

is

subjected

to

Several routes have been explored
including the rectum, vagina, lung

epithelium, and liposome therapy, but all have met with variable success.
Nasal delivery of insulin was found to be more effective than subcutaneous
injection of insulin in human studies, however,

the surfactants used

to gain transnasal entry (usually sodium glycolate) produces irritation
(Pontiroli, 1982).
The aim of this study is to explore the phosphorylated carbohydrate
as a carrier for the peptides.

Insulin was chosen as a model peptide

because it is easily obtainable, well characterized,

and a number of

biological, parameters of its activity have been described.

The plasma

membrane

of charged

provides

a highly

impermeable barrier

to entry
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molecules

or

large,

uncharged

polar molecules

into

the

cell.

This

barrier can be breached by specialized transport proteins which allow
passage

through

the membrane

(Wilson,

1978).

Large

molecules

like

proteins, polysaccharides, and polynucleotides are unable to use transport
proteins as a

route into the cell.

These macromolecules

enter the

cell primarily by endocytosis, either as the constitutive process of
f luid-phase endocytosis which allows generalized entry or through receptormediated endocytosis of specific types of macromolecules
1977).

Elucidation

of

the

process

of

(Silverstein,

receptormediated

endocytosis

resulted from the work of Goldstein and associates on the uptake of
cholesterol
receptor

by animal

and its

intracellular

Nobel prize in 1985
that

cholesterol

cells and

the subsequent
fate,

for which

discovery of the LDL
they were

(Goldstein, Anderson, & Brown, 1979).

binds

to

a

specific

extracellular

awarded

a

They found

receptor

on

the

plasma membrane after which the complex is collected into coated pits
which

are

internalized

as

coated vesicles

and

routed

where the complex is separated into ligand and receptor.
is then free to be recycled to the plasma membrane.

to

lysosomes,

The receptor

The transport of

macromolecules through coated pits has been found to include polypeptides
such as insulin, lectins, and toxins from plant and bacterial sources
(Sharon & Lis,

1972).

Although the pathways taken by these polypep

tides once inside the cell

are not

fully understood, most appear to

involve transport to lysosomes or endosomes as an initial step in intra
cellular processing

(Marnell, Shie, Stookey, & Draper, 1984; Bergeron,

Cruz, Kahn, & Posner, 1985).
Natowicz,

studying enzymes produced intracellularly but residing

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

primarily in lysosomes after dispersal from the Golgi apparatus, found
that molecules carrying a high content of phosphorylated mannose were
preferentially taken up by lysosomes
1979).

(Natowicz, Chi, Lowry,

&

Sly,

This implies that lysosomal enzymes which are exocytosed may

return to the cytosol through mannose-phosphate specific receptors on
the plasma membrane, which aggregate into coated vesicles and are endocytosed.

Mannose-6-phosphate

was

identified as

uptake signal on fibroblast lysosomal hydrolases
1979).

the high

lysosomal

(Von Figura &

Klein,

Kaplan and others, also using human fibroblasts noted that the

form of lysosomal enzymes that are rapidly internalized

("high uptake

form") are more acidic that forms which are internalized more slowly.
He proved that the acidic group responsible for the high uptake form was
the
Sly,

phosphate
1977).

group
He

associated

later used

with

D-mannose

the human

spleen

(Kaplan,
enzyme

Achord,

&

B-glucuronidase

to identify the specific phosphohexose related to high lysosomal uptake
as mannose-6-phosphate.

Mannose-6-phosphate

(or its

analogues)

are

recognized by receptors on the plasma membrane, initiating the receptormediated endocytosis of the enzyme carrying the signal

(Natowicz

et

al., 1979).
The idea of attaching the carbohydrate recognition signal to poly
peptides which did not normally carry it was explored by Lee, who found
these peptides could bind to the receptor and gain entry to the cell
through the mannose-6-phosphate moiety

(Lee &

Stowell,

1978).

The

castor bean toxin, ricin, has also been used to produce chimeric forms
with mannose-phosphate. Ricin consists of two subunits: the enzymatically
active A chain, which affects the function of Elongation Factor 2 of

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

protein synthesis, but is incapable of entering the cell and the binding
subunit

(B chain) which is not

membrane receptor allowing
associated A chain
successful

toxic alone, but binds to the plasma

adsorptive endocytosis

(Gilliland, 1978).

of

itself

and

delivering

the

the

Youle and associates were also

in attaching the enzymatic portion of the ricin

mannose-phosphate

and

ricin

A

toxin

to

chain

intracellularly

through the mannose phosphate receptor of the lysosome.

This was proved

by the exhibition of the toxic effects of the ricin on protein synthesis
(Youle, Murray, &

Neville, 1979).

The successful use of mannose-phosphate as a vehicle for intracellular
transport of toxins suggested further experimentation on the feasibility
of mannose-phosphate

as

a carrier for other polypeptides

into cells

which do not have specific receptors for the polypeptide or for gaining
entry by receptor-mediated endocytosis for peptides which do not normally
gain entry by this route.
In the present study, a mannose-phosphate obtained from yeast is
employed as a carrier system for insulin.
have

been

Hansenula,
Thieme &

obtained

from various

Phosphorylated oligosaccharides

genera

Saccharomyces, and Kloeckera.
Ballou,

1971)

of yeast

including

(Kocourek &

Candida,

Ballou,

1969;

Polymannose isolated from fungal sources is

usually associated with proteins and is known by the generic term "yeast
mannan".

These mannans

vary

both in mannose content

protein attached to the polysaccharide chain.

and amount

of

The main unifying char

acteristic of mannans is the high D-mannose content, in which they are
unique as a group of naturally occuring products.

In his

excellent

review on yeast mannans, Ballou (1979) ascribes the diversity in contri
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bution of protein to the mannan both to genus of yeast

from which It

Is Isolated and to the cellular location of the mannan.

Yeast mannans

are covalently linked polymannose-protein complexes, found coating the
cell and interspersed w i t h the cell wall.
the periplasmic

space

They can also be found in

associated with enzymes.

The

protein

content

varies from 5% in the "structural" cell wall associated mannan to 30-50%
in the enzyme-linked periplasmic types of mannans.
the

exposed

factors.

cell wall

and

Some mannans line

probably function as sexual

agglutination

The polymannose portion of the mannan is usually in the form

of a long chain of D-mannose in the alpha(l-6)
to 150 mannose units.

linkage, extending up

From the backbone chain,

side

chains

alpha(l-2) or 1-3) or mon o - to pentamannosides are found.
isolated

from

Saccharomyces

cerevisiae has

a

backbone

linked-

The mannan

chain

of

150

residues and side chains of up to four mannosides, with more that half
of the mannose present as side chains.

Glycopeptides from the mannans

are characterized by an unusually high content of serine and threonine,
up to 45%, but otherwise are not distinctive in amino acid composition.
The peptides are primarily linked to the mannoside through asparagine
via N-acetylD-glucosamine, although
through serine or threonine.

some oligosaccharides

The total

complex varies

are

linked

in molecular

weight from 25,000 to 250,000 daltons (determined by gel filtration).
The

mannans

used

in

this

study were

obtained

treated with a protease to reduce the native peptide.

commercially

and

They were covalently

bound to insulin in hopes of producing a carrier system allowing entry
of the insulin through the mannose phosphate receptor on the plasma mem
brane.

Rat

adipocytes were used as an in vitro system to test the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

11
efficacy

of the transport

and the degree of retention of biological

activity of insulin entering the cell through this pathway.
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MATERIALS AND METHODS

The yeast mannans

used

in

this

study were

obtained

from Sigma

Chemical Co., St. Louis, Missouri (from Saccharomyces cerevisiae, lot
number 33F-3878) and were subjected to analysis for carbohydrate, protein,
and phosphate content, as well as gel filtration to estimate molecular
weight.

All

chemicals used

unless otherwise indicated.

in

this

study were

obtained

from

Sigma

All radioactive compounds were from New

England Nuclear, Boston, Ma.
Carbohydrate analysis was done according to the Phenol-Sulfuric
Acid method of DuBois.

Samples were read at 487 nm and compared to a

standard curve of mannose (DuBois, Gilles, Hamilton, Rebers, &

Smith,

1956).
Protein content was determined by the method of Lowry using crystal
line Bovine Serum Albumin standards (Lowry, Rosebrough, Farr, & Randall,
1951).
Phosphate content was measured by the method of Gatt,
hydrolyzed and unhydrolyzed mannan were compared (Gatt &

in which

Borman, 1966).

The phosphate content of unhydrolyzed mannans were subtracted from the
hydrolyzed to give the bound phosphate content.
To estimate molecular weight, mannans were applied to a Sephadex
G100-40 column (47 cm x 1.9 cm) having a bed volume of 100 ml in 0.02
M Tris buffer, pH 7.4.

The elution of the mannan (25 mg/ 200ul) was

compared to standards of Dextran Blue (ca. 2,000,000 MW), pepsin (34,700

12
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MW), albumin (66,000MW), lysosome (14,300 MW), and Potassium permanganate
(75 M W

) to obtain an estimate of the molecular weight.

was run at a rate of 5 ml

/ hour and collected at

The column

12 ml/ tube.

The

yeast mannans elution peak was located by absorbance at 280 nm and by
carbohydrate analysis.
The ability of three proteases (papain, pepsin, and chymotrypsin)
to reduce the protein content of the mannan was compared by Lowry analysis.
Subsequently, agarose-bound chymotrypsin was chosen as the best enzyme
for this purpose.
shaking

Chymotrypsin (100 meg) was incubated overnight with

at room temperature with

10 mg

of native mannan in

lOmM Tris buffer with 0.1 M CaCl2 , pH 7.8.
centrifugation

1 ml

of

The enzyme was removed by

and the mannan was concentrated by precipitation with

50% ethanol.

Coupling Methods

Two methods of coupling insulin to the mannans were investigated.
The cyanogen-bromide method was followed according to Hitchcock-DeGregori
with some modifications

(Hitchcock-DeGregori

&

Yienger,

1984).

Under a hood, one milligram of cyanogen bromide in 1 ml of acetonitrile
was allowed to react at 20° with 10 mg of chymotrypsin-treated yeast
mannan.

The pH was maintained between 10-11 for approximately 20 minutes

or until

the pH stabilized by addition of small amounts of 6N NaOH.

(Cyanogen bromide should be used with caution since it can produce an
extremely

toxic cyanide gas.)

stabilized,

the

solution was

After
dialyzed

the pH of the reaction mixture
against

ice

cold water

hour and against cold acetate buffer for another hour.

for

The insulin
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was added in excess (1 m g with 20% as Fluorescein isothiocyanate-labeled
insulin)

to the mannans in Sodium Bicarbonate coupling buffer (0.2M)

and incubated overnight with shaking in the cold.

The mannan-insulin

was concentrated by ethanol precipitation, and washed twice with coupling
buffer. The precipitated mannan-insulin was resuspended in 1M ethanolamine
buffer pH 8.0 overnight

to block unreacted groups.

The complex was

precipitated in 50% ethanol, resuspended in coupling buffer and vortexed,
then precipitated again with 50% ethanol, followed by resuspension and
precipitation with ethanol, alternating between coupling buffer and acetate
buffer

(three times e a c h ) , finally resuspended

in

lOmM Tris-HCL

(pH

7.5) buffer for storage.
A disc gel electrophoresis (PAGE-SDS) was prepared according to
the instructions of LKB Bromma (LKB Application note 320), using a 7.5
% acrylamide in 0.375 M Tris-Glycine
for 90 minutes.

(pH 8.3) and run at 4 mA/ tube

Both ethanol precipitated and non-precipitated mannan-

insulin were compared with FITC-insulin and with native yeast mannan.
The SPDP-conjugated mannan-insulin was prepared by James Monticello
(Biomedical Sciences Dept., Western Michigan University) by crosslinking
the lysine 29 of insulin (B chain) with the heterobifunctional agent Succinimidyl-3
groups

of

(2-pyridyldithio)

the

insulin were

Proprionate

first

blocked

(SPDP).
with

The

alpha

citraconic

amino

anhydride

which was removed after SPDP treatment by reducing the pH. The PDP-insulin
was then exposed to yeast mannan previously treated to expose sulfhydryl
groups and allowed to react.
free

insulin

Iwamoto, &

from the

Extensive dialysis followed to help remove

coupled mannan-insulin

(Roth,

Maddux,

Goldfine, 1981).
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Wong,

15
Radi oimmunoas s ay

The

amount

of

insulin

bound

to

the mannans in each method was

quantitated by radioimmunoassay using the cellulose powder method
Zaharko (Zaharko

&

Beck, 1968).

The anti-insulin antibody was supplied

by the Upjohn Company as was use of the
(Model 1191) gamma counter.

of

Tracor Analytic

Gamma

Trac

Briefly, dilutions of the mannan-insulin

were allowed to react with anti-insulin antibody (200ul of 80,000 dilution)
for 2 hours at room temperature in the presence of lOuU of 125-Iodinated
Insulin. After incubation, the antibody-bound mannan-insulin was separated
from the unbound mannan-insulin by mixing with an excess of cellulose
(to which unbound insulin becomes attached.)

The cellulose-bound mannan-

insulin was then separated by centrifugation for 4.5 minutes at 3200
rpm, after which the supernatant was decanted and the cellulose pellet
counted on a gamma counter.

To quantitate the insulin present, a standard

curve of known amounts of insulin

(luU to 512uU) was run concurrently.

These values were compared using the Rodbard Statistical Program for radio
immunoassay (Rodbard

&

Hutt, 1974).

Adipocyte Preparation

Rat adipocytes were isolated by a modification of Rodbell's method
(Rodbell, 1964).

Only plastic or siliconized glassware should be used

to avoid disrupting the fat cells.
were used.

Adult male Sprague Dawley rats

Adipocytes were liberated from stromal cells and basement

membrane with Type II collagenase.

Silicone oil (bis 3,5,5,trimethyl-

hexyester) was obtained from AG Fluka (Hauppauge, NY).

Two

types of
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population were used: large adult male rats (weight averaging 400 grams)
and young

adult male rats

(weight averaging 120 - 150 grams).

rats were sacrificed by CO2 suffocation and epidydimal
asceptically removed.

These pads were

The

fat pads were

suspended in Fat Cell Buffer

(see Appendix) and treated with collagenase (2mg /ml) in a 37° C. water
bath with occasional agitation.

The total amount of collagenase varied

with the number of rats being processed,
small rats.

typically using 6 mg.

Treatment usually required about 45 minutes,

for 5

the extent

of digestion of collagen being estimated by clouding of the solution
as fat cells were freed.

The adipocytes were washed three times in warm

buffer to remove the enzyme, centrifuged at 400 rpm for 2 minutes each
time, and were then filtered through nylon hosiery to separate stromal
cells from the fat cells.
albumin

and

counted

on

The cells were resuspended in buffer lacking
a haemocytometer.

Approximately

500,000 cells are needed per tube in the assay.

300,000

to

To insure a homogeneous

suspension of fat cells during dispensing, enough buffer was added to
make

twice

the volume needed

for the entire assay.

The cells were

then aliquoted to 200-300ul / tube while being rapidly but gently stirred
on a magnetic stirrer.

Insulin Binding Assays

Cells were incubated-with fluorescein labeled native mannans for
45 minutes at 37° C. and in the cold.
with

unlabeled mannans

for

20 minutes

Another group was pretreated
prior

to incubation with

labeled mannans.
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the

The ability of the isolated adipocytes to recognize and bind insulin
was assessed by observing the binding
time.

Large

adult

of radio-labeled insulin over

rats were used in this study.

The

125 i-insulin

(25uU/tube) was added to aliquots of approximately 300,000 cells/tube.
Incubation times were 30, 60, and 120 minutes at 37°C with occasional
shaking.

The cells were separated from the buffer by centrifugation

with silicone oil

(AG Fluka), which results in a layer of adipocytes

floating on the oil layer over the buffer.

After washing in fresh buffer,

the cell layer was removed and counted in a gamma counter.
The adipocytes were used in a cell binding assay to compare the
mannan-insulin conjugates with native insulin for competitive inhibition
with 125 i-insulin.

Each assay tube contained 300,000-500,000 cells/tube

and radiolabeled insulin
or mannan-conjugated
50uU) was added.

(lOuU/tube).

insulin

Either

native

insulin

(cyanogen bromide conjugate^

(60uU)

25uU, PDP=

In addition, the mannan-insulins were also combined

with native mannans

(200mcg/tube).

A nonspecific binding tube with

100,0O0uU of unlabeled insulin was included.

The assays were done in

triplicate, unless otherwise noted.

All tubes were incubated at 37°

C for 45 minutes,

fresh buffer.

then washed with

After

separation

with oil, the cells were counted on a gamma counter to detect 125 i-insulin
bound.

Glucose Uptake Assays

To determine whether the mannan-insulin retained the capacity to
induce

characteristic

insulin

biological

used to measure uptake into the adipocytes.

effects,

14

C-glucose

was

Radiolabeled glucose (0.1
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uCi/tube) was added to approximately 500,000 cells/ tube,

and either

insulin (60ull or 120uU), mannan-insulin (25uU or 50uU), or no insulin
was also added.

Native mannans were added in high concentration (200

meg) or low concentration (20ug) instead of insulin in some tubes.

In

an attempt to block cell mannan binding sites, the native mannans (200uU)
were also added in combination with the both types of mannan-insulin
conjugates.

After incubation for 45 minutes at 37°C with occasional

shaking, the cells were separated with oil as described above and counted
in Scintisol on a Tracor Isopac beta counter.

Statistical Analysis

Statistical analysis was done using Student's T-test

(onetailed)

with p values at least p = 0.01 unless otherwise indicated.
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RESULTS

Characterization of mannans from Saccharomyces cerevisiae

The mannans have a molecular weight of 60,000 daltons, were 50 %
carbohydrate, 20 Z protein, and 7 Z phosphate by weight (Table 1). Ethanol
precipitation proved to be an effective means of separating the mannan
from aqueous solution.

After treatment with a protease (chymotrypsin),

precipitation of the mannan with an equal volume of ethanol (50Z aqueous
solution) removed most of the carbohydrate from the solution.

However,

13.5 meg of protein remained in solution while 12.8 meg was precipitated
with the carbohydrate.

This implies the protein remaining in solution

was removed from the glycoprotein by the protease.

Coupling the Mannan to Insulin

The Lowry method was used to compare the protein content before and
after chymotrypsin treatment.

The concentration of protein following

insulin conjugation by the cyanogen bromide method was also analysed.
To get an estimate of the carbohydrate to protein ratio, the native,
proteasetreated, and conjugated mannans were subjected to carbohydrate
analysis (Table 2).
The mannan-insulin was run on disc gel electrophoresis.

Native

mannan, Fluorescein isothlocyanate-labeled insulin, and Protein Standards
(Sigma Dalton VI) were also run.

Both ethanolprecipitated and nonprecip

itated mannan-insulin were included.

Appendix B shows the bands visible

19
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after staining with Coomassie blue R250.

The nonprecipitated mannan-

insulin shows three bands, one which co-migrated the same distance as
the FITC-Insulin.

The ethanol-precipitated mannan-insulin shows only

1 band, nearer the migration of the native mannan band.

This implies

that ethanol precipitation removes free insulin from the mannan-insulin
conjugate.
Radioimmunoassay

Radioimmunoassay showed the cyanogen-bromidemannan-insulin contained
5000uU/ml, while the PDP mannan-insulin contained 480uU/ml.
bromide method conjugates

The cyanogen

about 10 times as much insulin as does the

PDP method as previously described.

Adipocyte Preparation

Appendix C contains photographs of rat
digestion
size,

of

stromal

cells

but the younger

and

collagen.

adipocytes following the
The cells vary widely in

(smaller) rats appear

to have cells of a more

homogeneous distribution than the older (more obese) rats.

Adipocytes

are primarily vacuolated with triglyceride storage vesicles, restricting
the cytoplasm to the periphery of the cell.

Figure 2 shows the fluorescent

labeling acquired by cells incubated at 37o c .
was

seen in the cells incubated

with unlabeled mannans.

No binding of fluorescence

in the cold

or

in cells

pretreated

This implies a saturable binding of the mannan

to the cell surface receptors.
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Competitive Inhibition With Insulin

Epididymal adipocytes showed an increase in binding of radioactive
insulin over the 120 minute sampling period

(Table 3).

taken at 30 minute intervals for up to 120 minutes.
rapid uptake of the

125

i-insulin.

A sample was

The cells showed

Competitive binding between the

mannan-insulin and radiolabeled insulin for cell receptors was compared.
Nonspecific binding was about 7 per cent.
4.

The results are given in Table

Each mean counts/minute is the result

of at least

three

trials.

Maximum binding was determined by exposing the cells to 125 i-insulin
alone.

Fifty microunits of insulin or 60 uU of the mannan-insulin (PDP

method)

conjugate reduced the radioactive insulin bound by 55Z, while

half that amount of mannan-insulin

(cyanogen bromide method)

the binding significantly by 68 per cent.

reduced

Excess native mannans were

added to the mannan-insulin conjugates in an attempt to bind the cellular
phosphomannose sites and preclude access through the mannan portion of
the glycopeptide (single trials only). An average reduction of inhibition
in radioactive binding to 36

% was shown when mannans were added to

the mannan-insulin conjugates (Table 4).

Glucose Uptake

Since the adipocytes were able to recognize and bind the mannanassociated insulin, the next assay examined the biological activity of
the conjugates.

This was measured by the increase in glucose uptake

using l^C-Glucose.

There was a linear increase in glucose uptake with

increasing insulin concentration.

Fifty microunits

of

the

cyanogen
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bromide mannan-insulin conjugate gave similar results to the same con
centration of native Insulin
for

Its

ability

to affect

(which represents

10 times

(Table 5).
glucose

Native mannan was also tested

uptake.

The

lower

concentration

the quantity of insulin in ug present in

50 uU) had little effect, but the excess mannan (200 ug) had a statis
tically

significant

increase

in uptake

(Appendix D).

The reduction

of glucose uptake when excess mannan is competed with the mannan-insulin
conjugate is statistically significant, as is the increase in the presence
of mannan-insulin

alone when compared

to the glucose uptake when no

native insulin was added.
The

data

shown in Table

from

the same protocol with

6 and Appendix E.

the PDP-mannan-insulin is

All means

are calculated

from at

least three trials.
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Table 1

Characterization of the Mannans

Protein content

20 %

Carbohydrate content

50 %

Phosphate content

7 %

Molecular weight

60,000 daltons

Table 2

Protein

and Carbohydrate Content

Protein
Mannan

Carbohydrate

_________________________________
ug/ml

ug/ml

YM-Chymotrypsin

107

10800

YM-Insulin (CnBr)

151

1640
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Table 3

Binding of Radiolabeled Insulin to Rat Adipocytes

Time (minutes)

Counts per minute

0 (Background)

150

30

1235

60

2071

120

2327

Table 4

Competitive Inhibition of Noniodinated insulin and Mannan-insulin
Against 125ins u iin j[n Ra t Adipocytes

Insulin Type

Mean Counts/Minute

Per Cent Inhibition

Radiolabeled insulin only

2682

0

Noniodinated insulin (60uU)

1217

55 *

Mannan-insulin Cyanogen Br.
(25uU)

849

68 *

Mannan-insulin PDP
(50uU)

1205

55

Mannan/Mannan insulin (CnBr)
(25uU)

1790

34

Mannan/Mannan insulin (PDP)
(50uU)

1639

39

* Statistically significant
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Table 5

Adipocyte Uptake of 14 C-Glucose
In the Presence of Insulin and Mannan-insulin (Cyanogen Bromide)

Insulin

Mean cpm

(amount)

No Insulin

414

A

Native insulin (lOOuU)

746

B

Native insulin (50uU)

1271

Mannan insulin

1384

A,C

551

C,D

(50uU)

Mannan (200ug)/Mannan-insulin (50uU)
Mannan only (200ug)
Mannan only

1129

(20ug)

671

A,B,D,E
C,E

Explanation of statistical significance designated by letters:
the value at each letter is significantly different from other values
with that same letter.

Table 6

Adipocyte Uptake of 14 c-Glucose (PDP)

Insulin (amount)

No insulin
Insulin

(50uU)

Mannan-insulin (50uU)
Mannan (200ug)/Mannan-Ins.(50uU)

Mean cpm

773
1202
1689
263
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DISCUSSION

Mannans are a heterogenous group of proteoglycans, unique in having
phosphorylated mannose as their primary carbohydrate. The values obtained
for

carbohydrate

and

within the range for

protein

constituents

and

molecular

weight

are

Saccharomyces cerevisiae as found by Ballou in

his review of the structure and composition of yeast mannans (Ballou,
1974). However, Ballou found that the degree of measurable phosphorylation
depended

on

the method

of

acetolysis

used

in

preparing

the mannans

from yeast cells, since cell wall isolated mannan differ in phosphorylation
levels

from mannans

isolated from whole cell homogenates.

ratios of carbohydrate : phosphate varying from 50 to 150.
in

this

experiment

would

than in Ballou's review,

indicate

a

lower

level

of

He

found

The 7% found

phosphorylation

but in another analysis of cell wall mannan

chemotypes by Cawley, the possibility of two chemotypes for Saccharomyces
cerevisiae is discussed.

One is the highly phosphorylated mannotriose

side chain containing mannan, while the other variety contains a tetramannose

side chain and lower

Ballou, 1972).
be

found

in

levels

of phosphorylation

(Cawley

&

To determine if high and low phosphorylated forms could

our mannans,

the mannan was

separated by DGAG Sephadex

(A-50-120) chromatography (in 0.025M Tris-HCL, pH 8.0, with a 0.05M 0.5M NaCl gradient).

A single peak was eluted, implying only one level

of phosphorylation.
Prior to coupling insulin to the mannan, some of the native peptide
was cleaved by treatment with the protease chymotrypsin, resulting in
26
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about a fifty per cent reduction in resident protein on the mannan.
This was done in an attempt to lower the antigenicity of the carrier
and to reduce peptide content

prior

to

the addition

of

insulin

(MW

6000).
Two methods of coupling mannan to insulin were employed in order
to create carriers with varying amounts of insulin.

The cyanogen bromide

method involves reaction at alkaline pH of the cyanogen bromide with
hydroxyl

groups on the carbohydrate,

resulting in

the production

cyanamides with the alpha amino groups of proteins
Grnback, 1967).

(Axen,

Porath,

of
&

When used with a glycoprotein with a high carbohydrate

content as in yeast mannan, multiple insulin binding sites should be
available on the mannose.

The SPDP method, however, is a peptide-to-

peptide heterobifunctional

crosslinker,

sulfhydryl groups on one of peptides.

and requires

the presence of

SPDP contains a hydroxysuccinimide

ester group on one end which reacts with groups of peptides to form
amide groups, and also contains a pyridylsulfide group capable of reacting
with thiols to form disulfide bonds (Jou, Mazzaferro, Mayers,
1983).

& Bankert,

The protocol used to produce this PDP-insulin blocked the alpha

amino groups of insulin, allowing binding to lysine residue 29 of the
B chain

(Roth

et al.,

1981).

This reaction has the advantage of

proceeding under conditions of neutral pH and may be less destructive
to biological molecules than the alkaline pH required with cyanogen bromide
coupling.
of

Since the peptide component of the mannan provided only 10%

the glycopeptide,

bound by this method.

the supposition was that

less insulin would be

Radioimmunoassay results of comparable amounts

of both mannan-insulin conjugates show the cyanogen bromide mannan has
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incorporated about 10 times the amount of insulin as the PDP method.
Validity of

the radioimmunoassay

for the mannan-insulins compared to

native insulin was difficult to determine.

Since it was not possible

to establish concentrations of insulin in the mannan-insulin directly,
binding curves for the conjugates could not

be made.

The amount

of

insulin bound to the conjugate was found by Lowry analysis to be about
44mcg/ ml or llOOuU/ ml.

The RIA method is considered to be ten times

as sensitive for measurement in this range, so the RIA value for insulin
in the mannan-insulin of 5000uU is reasonably close.
probably

Since the RIA is

the more accurate value, all concentrations are expressed as

measured by RIA. After conjugation of insulin and mannan was accomplished,
the problem of removing unreacted insulin still in solution remained.
Affinity

chromatography with

the

lectins

Concanavalin

A

and

Lentil

lectin was explored, as well as the production of an anti-insulin affinity
column.

The lectin columns preferentially bind the mannose residues,

allowing free insulin to escape in the void volume.
mannans

(both insulin-bound

and mannan not

coupled

After elution of
to

insulin)

with

methylmannoside, the mannans were applied to the anti-insulin column.
Elution was accomplished by lowering the pH.

The presence of mannan

insulin was detected by carbohydrate and protein analysis (as previously
described).

Although this

free from bound insulin,
mannan remained.
less

potent

scheme did produce a good

separation of

only 2 meg of a starting total of lOmg.

of

This may have been due to a variety of factors, including

than

specified

anti-insulin

antibody

(used

to make

the

column), destruction of the antibody when binding to the column, less
than complete elution from the lectin columns, are among the more likely.
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A faster, more productive way to separate the mannan-insulin from
free

insulin was

ethanol.

found by

Mannan-insulin

precipitating the mannan-insulin with 50%

before

and

after

ethanol

compared by polyacrylamide electrophoresis.
visible in the ethanol precipitated band.

precipitation was

No free insulin band was
In subsequent experiments,

conjugates were prepared by the ethanol precipitation method.
One of the major questions
was how binding of
binding

in further experimentation

the insulin attached to mannans would compare to

of native insulin by

able to bind the fat cells,
initiate

addressed

a characteristic

the adipocytes.

the ability of the conjugated insulin to

insulin effect

glucose into the cell) would

If mannan-insulin was

(the increase

also be investigated.

of uptake

of

The in vitro assay

for efficacy of the chimeric insulin was tested using a modification
of Rodbell's rat adipocyte system.
The mannan-insulin was able to compete with the radiolabeled insulin
for cellular receptors at a significant level.

Since the supply was

limited, the PDP conjugated mannan-insulin was only done in two trials.
This may be the reason it is not statistically significant, even though
at

the same concentration it has

the native insulin.

the same per cent of inhibition as

In an attempt to block cellular mannose-phosphate

binding sites, the mannan-insulin was added to the cells in combination
with a large quantity of native mannan.

This resulted

in decreased

inhibition of the 125 i-insulin, which may have been due to competition
for mannose-phosphate binding sites, but does not prove that mannosephosphate receptors were the binding site.
mannans

prevents

cellular

binding when

Pretreatment with unlabeled
adipocytes

are

subsequently
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treated with fluorescent-labeled mannans.

This suggests the presence

of functional, saturable mannan receptors on the adipocytes.

Blocking

the exposed insulin with

cellular

anti-insulin

antibody

or

blocking

insulin receptors with anti-receptor antibody might be tried to eliminate
binding through the insulin moiety.
the

mannan-insulin

is

binding

The question still remains whether

the mannose-phosphate

receptors,

the

insulin receptors, or both.
The ability of the mannan-insulin to initiate a biological effect
was examined.

Insulin is known to affect fat cells by

uptake of glucose from the surrounding medium,

increasing the

a parameter which is

easily measured with 14 c-Glucose. Rodbell (1964) found the glucose uptake
was most effectively increased by addition of insulin in the 10 uU to
lOOuU range in animals fasted overnight.

He observed an increase in

the glucose uptake of 1.6X when lOOuU of insulin was added to the cells
for 2 hours at 37o.

Similar results were obtained with 100 uU of insulin

(1.8X increase). The conjugated insulins were able to produce results
that correspond to, but are not significantly greater than, an equivalent
amount of native insulin.

With the mannan-insulins and the 50uU insulin,

the increase in glucose uptake was three times the uptake when no insulin
was added the cells.

The reduced effect at the higher insulin concen

tration may have been due to the influence of negative cooperativity
or down regulation of the cellular receptors.
regulation,

i.e.,

the loss of cell

The phenomenon of down

surface receptors in response to

exposure to insulin, has been analyzed by a number of researchers (Berhanu
et al., 1982;
1985).

Marshall

&

Olefsky, 1981;

Garvey, Olefsky, & Marshall,

Insulin is also known to regulate binding by altering receptor
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affinity (Czech, 1985).
Another interesting aspect of the effect on glucose uptake was the
interaction of the native mannan with the adipocyte (with no insulin
added) and when mannan-insulin is present. Mannans in 20mcg concentration,
which is about 10X the amount of insulin in 50uU, caused no significant
increase in glucose uptake.

However, when the mannan was added in excess

(200mcg) , an insulin-like activity was initiated.

The high concentration

of mannan was initially used to attempt to block cellular mannose-phosphate
receptors and added to the fat cells in combination with the mannan-insulin
conjugate.

When

added

in

conjunction with

the mannan-insulin,

the

combined effect was not significantly different from the basal level of
glucose uptake.

Compared to the glucose uptake from the mannan-insulin

or the high concentration mannan alone, it was significantly different.
The PDP method mannan-insulin produced similar responses.
of mannan against mannan-insulin
trials.
effect

The

native

through

insulin-like

activity

Barham,

of

has

1971;

cellular

been

Pilch &

agents
Czech,

may

receptors.

reported

antibody-mediated

crosslinking

less marked

(high concentration)

crosslinking

Concanavalin A,
the use

mannan

conjugate was

with

The inhibition

be

The

1979;

its

production

trypsin,

disuccinimyl

these

exerting

lectins

(anti-receptor antibody),

like

in

suberate

Keilacker, Knospe,

of

like

and with
(Kono

&

Ziegler,

&

Whittaker, 1985).
The

native

mannan-induced

increase

in

glucose

uptake

could

be

explained in terms of the crosslinking theory, but the inhibition of
mannan-insulin responses in the presence of native mannan still remains
unresolved.

It

could

be

the

result

of

mannan-induced

crosslinking
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preventing the action of
could

also

receptors

be
by

the
the

the insulin bound

result

of

blockage

excess mannan,

thus

of

to the conjugate,

but it

cellular mannose-phosphate

preventing

the

binding by

the

conjugate.
It would be helpful to extend the experiment to some type of cells
known to have reduced numbers of insulin receptors or deficient insulin
receptors.

Insulin-like

the result
still

from binding

leave

questions

effects

under

these

at mannosephosphate

concerning

just

how

circumstances might
receptors.

This

be

would

the insulin-like activity

was being initiated, i.e., whether the mannan was acting to bring insulin
in proximity to its receptors, accelerating aggregation and internal
ization.
The role of internalization is still ambiguous in the literature.
Some researchers believe it is necessary for insulin down regulation
(although the fate of the receptor is widely debated), others point to
the insulin receptors at intracellular sites like the Golgi and nuclear
membrane and question the relationship to internalization and plasma
receptor binding (Fehlman, Carpentier, Van Obberghen, Freychet, Thamm,
Saunders,
&

Brandenburg,

&

Matsuoka, 1984; Bergeron

Orci,

1982;

Nakao,

Kagawa,

Shimizu,

Jha,

et al., 1985).

This controversy points out one possible use for conjugates which
allow entry of insulin through other receptors to elucidate the role,
if any, of the intracellular insulin receptors. Mannan-insulin conjugates
could also be used to deliver insulin to cells with defective receptors,
like those found in patients suffering from

diabetes mellitus type II

(NIDDM).
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While insulin was chosen as a model
this

study,

the mannan

carrier was

peptide for

envisioned

as

the carrier in

a general

peptide

carrier, able to be used for a wide variety of peptide transport problems.
For example, it might be useful to carry antimicrobial agents into the
macrophage,

since

some pathogenic organisms

(e.g.,

Brucella species)

can be sequestered there. Peptides might be introduced through mannosephosphate receptors into cells which they normally can not enter. This
might be useful in helping to understand the mechanisms of peptide activity
within

cells.

For

peptides

administered

orally,

the

mannans

provide protection from breakdown in the gastrointestinal tract.
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APPENDIX A

Buffer for Adipocyte Assays

HEPES Stock Buffer (500 ml)
131mM Sodium chloride

19.16 grams

4.8mM Potassium chloride

0.90 grams

1.3mM Calcium chloride

0.48 grams

0.9mM Potassium phosphate

0.41 grams

1.45mM Magnesium Sulfate (heptabasic)

0.74 grams

25mM HEPES

14.9 grams

Use sterile H 2O, adding one ingredient at a time with stirring.
Bring to 500 ml with H 2O.

To use, take 1 part of the stock above

to 4 parts sterile H 2O, then add 2.0 grams of Bovine Serum Albumin
and 20 m g / 100 ml D-glucose.

Bring to pH 7.4 with NaOH.

If kept refrigerated, the stock buffer is good for 30 days.

34
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APPENDIX C

Figure 1.

Isolated rat epididymal adipocytes (100X)

Figure

Adipocytes a-fter exposure to Fluorescein isothiocyanate
labeled yeast mannans (400X)
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APPENDIX B

Polyacrylamide Gel Electrophoresis

Protein standards (1), FITC-Insulin (2), Non-ethanol precipitated Mannan
-Insulin (3), Ethanol precipitated Mannan-Insulin (4), and Native Mannan
(5) were electrophoresised on 7.5% Polyacrylamide gel with SDS for 90
minutes at 4 mA/tube.
After fixation and staining with Coomassie blue
R250, these bands were visible. Note the multiple bands in 3 and single
band in 4 and 5.

Diagram o f Band P a tte rn o f Disc Gels
1

2

3

4

5

14300 D.
45000 □.

66000

D

.

60 MB

600 MS

500 Ml

500 Ml
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APPENDIX D

Glucose Uptake With Cyanogen Bromide Method

The capacity to increase uptake of glucose into the adipocytes was
measured as counts per minute of 14C—Glucose taken into the cells after
45 minutes in the presence of insulin, mannan-insulin, or native
mannans.
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APPENDIX E

Glucose Uptake With PDP Method

This graph represents the comparison of glucose uptake when Mannan-insulin
using the PDP conjugation method is tested.
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